Occudo Quantitative Strategies’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-95,114
Closed -$202K 1275
2022
Q3
$202K Sell
95,114
-85,636
-47% -$181K 0.02% 962
2022
Q2
$242K Sell
180,750
-40,382
-18% -$59.9K 0.02% 854
2022
Q1
$467K Buy
+221,132
New +$538K 0.04% 676

Other funds holding PGEN

Occudo Quantitative Strategies's PGEN Position: Q4 2022 in Review

Occudo Quantitative Strategies sold out of Precigen (PGEN) in Q4 2022, closing a stake of 95,114 shares — an estimated $202K sold.

Occudo Quantitative Strategies first reported a position in PGEN in Q1 2022 and held it in 3 quarters. The position peaked at $467K in Q1 2022. 161 funds tracked by Wall St. Rank hold PGEN as of Q4 2022.

  • Occudo Quantitative Strategies reported no remaining Precigen position as of Q4 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 95,114 Precigen shares in Q4 2022, an estimated $202K.
  • Occudo Quantitative Strategies first reported a position in Precigen in Q1 2022 and held it in 3 quarters.
  • Occudo Quantitative Strategies's Precigen position peaked at $467K in Q1 2022.
  • 161 funds tracked by Wall St. Rank held Precigen as of Q4 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.